clinical features and treatment outcomes of primary immune thrombocytopenic purpura in hospitalized children under 2-years old

Authors

h farhangi department of pediatric hematology and oncology, dr sheikh pediatric hospital, mashhad university of medical sciences (m

a ghasemi department of pediatric hematology and oncology, dr sheikh pediatric hospital, mashhad university of medical sciences (mسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

a banihashem department of pediatric hematology and oncology, dr sheikh pediatric hospital, mashhad university of medical sciences (mسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

z badiei department of pediatric hematology and oncology, dr sheikh pediatric hospital, mashhad university of medical sciences (mسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

abstract

abstract background immune thrombocytopenic purpura (itp) is the most prevalent cause of thrombocytopenia in children. despite the importance of itp in children under 2- years old, only a few publications are available in the literature. itp usually presents itself as   isolated thrombocytopenia and mucocutaneous bleeding. materials and methods this study was conducted on 187 under 2- year-old children diagnosed with itp and treated at dr. sheikh hospital from 2004 to 2011.in this retrospective study, clinical symptoms, laboratory findings, history of viral infections, vaccination history, and treatment efficacy in children under 2- years old with itp were investigated.patients were followed for one year after being discharged from the hospital. results the risk of the disease developing into chronic form was higher in older children (0.001). itp in children under 3-months old was significantly associated with vaccination (p=0.007). there was no significant differences between male and female patients in regards to newly diagnosed itp, persistent, and chronic disease status (p = 0.21). no significant difference in bleeding symptoms was observed between patients under 3-months old and 3 to 24-months old (p=0.18). conclusion infantile itp respond favorably to treatment. the risk of the disease developing into chronic form is higher in 3-to-24-month-old children compared to under-three-month olds.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old

Abstract Background Immune thrombocytopenic purpura (ITP) is the most prevalent cause of thrombocytopenia in children. Despite the importance of ITP in children under 2- years old, only a few publications are available in the literature. ITP usually presents itself as   isolated thrombocytopenia and mucocutaneous bleeding. Materials and Methods T...

full text

Clinical Features and Treatment Outcomes of 132 Infants with Immune Thrombocytopenic Purpura

Introduction: To determine common clinical symptoms, admission length, and treatment outcomes of infants with Immune Thrombocytopenic Purpura. Method: analysis of 132 infants with Immune Thrombocytopenic Purpura admitted to the emergency and hematology ward of Dr. Sheikh Hospital, with reference to age, gender, immunization history (preceding six weeks), presenting clinical features, treatment...

full text

clinical features and treatment response of immune thrombocytopenic purpura in infants

to determine the clinical features and treatment outcomes of infant with immune thrombo-cytopenic purpura (itp). retrospective analysis of 96 infant itp patients treated from 1995 to 2005. the data abstracted comprised age, gender, clinical features, and treatment outcomes. the 56 male and 40 female infants had a median age of 3 months. eighty presented with purpura, sixteen with active mucosal...

full text

Immune Thrombocytopenic Purpura: Etiopathogenesis, Clinical Features and Diagnosis

Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by increased platelet destruction. It is seen in children where it is usually acute and selflimited, and also occurs in adults, where it is insidious in onset and usually chronic in nature. Among adults it is thought to predominantly affect young women, although this view has been challenged by recent epidemiological ...

full text

Acute Immune Thrombocytopenic Purpura in Infants

Abstract Objective Immune thrombocytopenic purpura (ITP) manifests as an easy bruising or extravasation of blood from capillaries into skin and mucous membranes. The characteristics of acute ITP in infants have rarely been described. In order to better understand acute ITP in infants, the characteristics of the disease at this age group was investigated. Material and Methods The present des...

full text

Epidemiology of Idiopathic Thrombocytopenic Purpura in Children

Abstract Background Immune thrombocytopenic purpura (ITP) is a common autoimmune bleeding condition in children that is characterized by a decrease in the platelet count. The aims of this study were to define epidemiologic features of patients with primary ITP who were admitted to Mofid Children's Hospital, Tehran, Iran, in a 5-year period. Methods We retrospectively studied the records of ...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pediatric hematology and oncology

جلد ۶، شماره ۱، صفحات ۲۴-۳۱

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023